2020 JUN 03 Why ICMR Continues to Stand Firm on Using Hydroxychloroquine as Prophylaxis

A recent case-controlled study by Indian Council of Medical Research (ICMR) has underlined the benefit of hydroxychloroquine (HCQ) as prophylaxis, showing that the sustained use of the anti-malaria drug along with the use of personal protective equipment (PPE) was associated with a significant decline in risk of COVID-19 infection rate by up to 80% among the health care workers. Continue Reading